Ambev (NYSE:ABEV) Reaches New 1-Year Low at $2.24

Ambev S.A. (NYSE:ABEV - Get Free Report)'s share price reached a new 52-week low during trading on Thursday . The stock traded as low as $2.24 and last traded at $2.27, with a volume of 672608 shares changing hands. The stock had previously closed at $2.26.

Analysts Set New Price Targets

Several research analysts have issued reports on the company. StockNews.com assumed coverage on Ambev in a research report on Friday, January 26th. They issued a "buy" rating on the stock. Barclays downgraded Ambev from an "overweight" rating to an "equal weight" rating and decreased their price objective for the stock from $3.50 to $3.00 in a research note on Monday, March 4th. Finally, JPMorgan Chase & Co. reaffirmed a "neutral" rating on shares of Ambev in a research note on Friday, March 1st. Four research analysts have rated the stock with a hold rating and four have given a buy rating to the company. According to data from MarketBeat, Ambev currently has an average rating of "Moderate Buy" and an average price target of $3.20.

Ambev Stock Up 1.3 %

The firm has a market capitalization of $36.07 billion, a PE ratio of 12.72, a PEG ratio of 2.28 and a beta of 1.08. The company has a fifty day moving average price of $2.49 and a 200-day moving average price of $2.63. The company has a debt-to-equity ratio of 0.03, a quick ratio of 0.66 and a current ratio of 0.89.

Ambev (NYSE:ABEV - Get Free Report) last announced its quarterly earnings data on Thursday, February 29th. The company reported $0.06 earnings per share for the quarter, beating analysts' consensus estimates of $0.05 by $0.01. The business had revenue of $4.04 billion for the quarter. Ambev had a return on equity of 17.60% and a net margin of 18.19%. As a group, analysts expect that Ambev S.A. will post 0.19 earnings per share for the current year.

Institutional Trading of Ambev

Several institutional investors have recently bought and sold shares of ABEV. Raymond James & Associates grew its stake in shares of Ambev by 37.0% in the first quarter. Raymond James & Associates now owns 1,039,250 shares of the company's stock valued at $3,357,000 after buying an additional 280,753 shares in the last quarter. Bank of New York Mellon Corp grew its stake in Ambev by 7.5% during the 1st quarter. Bank of New York Mellon Corp now owns 3,788,023 shares of the company's stock worth $12,235,000 after purchasing an additional 264,696 shares in the last quarter. American Century Companies Inc. grew its stake in Ambev by 38.7% during the 1st quarter. American Century Companies Inc. now owns 503,973 shares of the company's stock worth $1,628,000 after purchasing an additional 140,617 shares in the last quarter. Cambridge Investment Research Advisors Inc. lifted its holdings in shares of Ambev by 35.3% in the 1st quarter. Cambridge Investment Research Advisors Inc. now owns 35,172 shares of the company's stock valued at $114,000 after purchasing an additional 9,168 shares during the last quarter. Finally, HighTower Advisors LLC lifted its holdings in shares of Ambev by 3.9% in the 1st quarter. HighTower Advisors LLC now owns 131,259 shares of the company's stock valued at $424,000 after purchasing an additional 4,984 shares during the last quarter. 8.13% of the stock is owned by institutional investors and hedge funds.

About Ambev

Ambev SA, through its subsidiaries, engages in the production, distribution, and sale of beer, draft beer, carbonated soft drinks, other non-alcoholic beverages, malt, and food products. It offers beer primarily under the Skol, Brahma, Antarctica, Brahva, Budweiser, Bud Light, Beck, Leffe and Hoegaarden, Bucanero, Cristal, Mayabe, Presidente, Presidente Light, Brahma Light, Bohemia, The One, Corona, Modelo Especial, Stella Artois, Quilmes Clásica, Paceña, Taquiña, Huari, Becker, Cusqueña, Michelob Ultra, Busch, Pilsen, Ouro Fino, Banks, Deputy, Patricia, Labatt Blue, Alexander Keith's, and Kokanee brands.